Who we are

What is Glycoscience

Are glucides sweet?

Glycoscience in one minute

Introduction to the Glycoscience

• Part 1　Invitation to Glycoscience

• Part 2　Fertilization

• Part 3　Source of Energy

• Part 4　Extracellular matrix 1

• Part 5　Extracellular matrix 2

• Part 6　Cell proliferation and differentiation

• Part 7　Blood type

• Part 8　Cancer

• Part 9　Viral infection

• Part 10　Applications and Developments

”Hyaluronic Acid” Expedition

Hyaluronic Acid - I am also in your home

Hyaluronic Acid- Everywhere in your body

Hyaluronic Acid- This is what I am!

Hyaluronic Acid- How I work in your body

Story Time

Our R&D

R&D Basic Policy

R&D Structure

R&D Pipeline

Process of new drug development

Intellectual Property

Sustainability

Sustainability Management

Materiality

Stakeholder Engagement

Environmental Policy

Environmental Impact Reduction Initiatives

Initiatives for Biodiversity

Information Disclosure Based on
the TCFD Recommendations

Social Contribution Activities

Human Resource Development

Diversity and Work-Life Balance

Corporate Governance

Compliance

Risk Management

Our Policy

ESG Data Book

External Evaluations

Investors

News Release

What's New

Management Policy

• Message from President & CEO

• Mid-term Management Plan

• R&D Pipeline

• Profit Distribution Policies

• Business Risks

Highlights

• Business Performance

• Business Performance（Quarter）

• Cash Flow

• Business Performance Data Download

IR Library

• Summary of Financial Results

• Presentation Material

• Corporate Report

IR Schedule

Shareholder Information

• Stock Information

• Shareholder Composition

• Profit Distribution

• General Meeting of Shareholders

• Analyst Coverage

• Stock Price

IR E-mail Alert

Our Company

Greeting

Corporate Philosophy

History

Corporate Profile

Member of the Board

Organizational Chart

Corporate Governance

Compliance

Value Creation Process

Social Contribution Activities

Business Activities

• Business Segment

• Products
  • Pharmaceuticals and Medical Devices
  • Bulk Products
    • Sodium Hyaluronate
    • Sodium Chondroitin Sulfate
  • LAL Business
  • Contract development and manufacturing organization (CDMO)

• Production

• Quality Compliance